GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Iran Daru (XTEH:IRDR1) » Definitions » 5-Year Yield-on-Cost %

Iran Daru (XTEH:IRDR1) 5-Year Yield-on-Cost % : 3.55 (As of Jun. 14, 2024)


View and export this data going back to 1990. Start your Free Trial

What is Iran Daru 5-Year Yield-on-Cost %?

Iran Daru's yield on cost for the quarter that ended in . 20 was 3.55.


The historical rank and industry rank for Iran Daru's 5-Year Yield-on-Cost % or its related term are showing as below:

XTEH:IRDR1' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 5.71
Current: 3.55


During the past 0 years, Iran Daru's highest Yield on Cost was 5.71. The lowest was 0.00. And the median was 0.00.


XTEH:IRDR1's 5-Year Yield-on-Cost % is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.25 vs XTEH:IRDR1: 3.55

Competitive Comparison of Iran Daru's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Iran Daru's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Iran Daru's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Iran Daru's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Iran Daru's 5-Year Yield-on-Cost % falls into.



Iran Daru 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Iran Daru is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Iran Daru  (XTEH:IRDR1) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Iran Daru 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Iran Daru's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Iran Daru (XTEH:IRDR1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Ayatollah Saeedi Highway, End Of Kermani Street, Moallem Boulevard, Tehran, IRN, 1371658111
Iran Daru is a pharmaceutical company based in Iran. It manufactures and sells pharmaceutical products for antibiotics, cardiovascular agents, and local anesthetic agents. The company manufactures products in three main dosage form categories namely solid, semi-solid, and liquid including tablets, capsules, pellets, sachets, gels, creams, ointments (sterile and non-sterile), spray solutions, and syrups. Products offered by Iran Daru include Diclofenac Potassium, Biotin 5 mg, Tetracycline, Folic acid, Meloxicam, Acetaminophen and Caffeine, and Levocetirizine dihydrochloride, among others. It also exports its products to other countries.

Iran Daru (XTEH:IRDR1) Headlines

No Headlines